Racclean Biotechnology Incorporation
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
"Metide - The Peptide Expert." Babetide™ antimicrobial peptide features potent antimicrobial activity, high safety and stability, and zero skin irritation, serving as a novel alternative to existing antibiotics or traditional preservatives and antimicrobial agents.
The content above was translated by Ai
Founded Year
2020
Unified Business No.
83716776
Status
Closed
Number of Employees
0
Total Paid-in
Capital
10,000,000 (NT$)
Location of Company
Taiwan
, Taichung City
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Racclean Biotechnology Incorporation was established in 2020, bringing together a team of master's and doctoral experts specializing in peptide research, development, and manufacturing processes. With the rapid development of biomedical technology, a new type of biomolecule, "peptides," has gradually gained attention and been applied across various industrial fields. We integrate academia and research, listen to the needs of all parties, and dedicate ourselves to the development of functional peptide products and novel drugs, aiming to serve as a bridge between academic institutions and the general public. By applying core technologies to reduce the mass production costs of peptides, we accelerate the development of functional peptide products to provide access to highly specific and safe peptide raw materials.
The content above was translated by Ai
